Experimental treatments could help US Ebola patient - Reuters
Experimental treatments could help US Ebola patient Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOdnBLcDlGZE5uM1MycHlNMkxVNFd3VkJJNHF0bUstQTFtcDREM2NIclR4RG9QQWJFZnl2QTdzclA1UjVHQ0RtM2FWOF8tZDB5Z2oyZ0tzdEpCOXpEUTRpXy00bkE4am5rbjROS1hzSVpmcF9zMWs0VnB4OFVMNW9lejFaSEVVdGlmSV91WTJFMUlDelJOSXlybGhiM0ptN0JCcUZPVVpYbw?oc=5" target="_blank">Experimental treatments could help US Ebola patient</a> <font color="#6f6f6f">Reuters</font>
A U.S. missionary diagnosed with Ebola is receiving experimental treatments in a German hospital, including drugs aimed at reducing disease symptoms and other therapies, as no approved treatments exist for the Bundibugyo strain of Ebola.
The U.S. missionary diagnosed with Ebola is undergoing treatment in Germany, receiving drugs aimed at reducing disease symptoms and other therapies, as no approved treatments exist for the Bundibugyo strain of Ebola.
The U.S. missionary diagnosed with Ebola is receiving experimental treatments in a German hospital, including drugs aimed at reducing disease symptoms and other therapies, as no approved treatments exist for the Bundibugyo strain of Ebola.
Similar Stories
Related coverage based on topic and tags
Pope Leo urges global action to confront Congo's Ebola outbreak - Reuters
Pope Leo urges global action to confront Congo's Ebola outbreak Reuters
August 23, 2026 at 11:14 AMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PM| Reuters - Reuters
| Reuters Reuters
August 27, 2026 at 01:06 AM